Advocate (4 - 8 kg)
ATC code
Species
Cats and ferrets.
Indications
For cats suffering from, or at risk from, mixed parasitic infections. The veterinary medicinal product is only indicated when use against fleas and one or more of the other target parasites is indicated at the same time:
• the treatment and prevention of flea infestation (Ctenocephalides felis),
• the treatment of ear mite infestation (Otodectes cynotis),
• the treatment of notoedric mange (Notoedres cati),
• the treatment of the lungworm Eucoleus aerophilus (syn. Capillaria aerophila) (adults),
• the prevention of lungworm disease (L3/L4 larvae of Aelurostrongylus abstrusus),
• the treatment of the lungworm Aelurostrongylus abstrusus (adults),
• the treatment of the lungworm Troglostrongylus brevior (adults),
• the treatment of the eye worm Thelazia callipaeda (adults),
• the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis),
• the treatment of infections with gastrointestinal nematodes (L4 larvae, immature adults and adults of Toxocara cati and Ancylostoma tubaeforme).
The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
For ferrets suffering from, or at risk from, mixed parasitic infections. The veterinary medicinal product is only indicated when use against fleas and the prevention of heartworm disease is indicated at the same time:
• the treatment and prevention of flea infestation (Ctenocephalides felis),
• the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis).
Dose to be administered and administration route
To ensure a correct dosage, body weight should be determined as accurately as possible.
Dosage schedule for cats:
The recommended minimum doses are 10 mg/kg bodyweight imidacloprid and 1.0 mg/kg bodyweight moxidectin, equivalent to 0.1 ml/kg bodyweight of the veterinary medicinal product.
For treatment or prevention of infestations with the parasites indicated for use of this veterinary medicinal product, the need for and frequency of re-treatment(s) should be based on professional advice and should take into account the local epidemiological situation and the animal’s lifestyle.
Weight of cat [kg] |
Pipette size to be used |
Volume [ml] |
Imidacloprid [mg/kg bw] |
Moxidectin [mg/kg bw] |
≤ 4 kg |
Advocate for small cats |
0.4 |
minimum of 10 |
minimum of 1 |
> 4–8 kg |
Advocate for large cats |
0.8 |
10–20 |
1–2 |
> 8 kg |
the appropriate combination of pipettes |
Flea treatment and prevention (Ctenocephalides felis)
One treatment prevents future flea infestation for 4 weeks. Existing pupae in the environment may emerge for 6 weeks or longer after treatment is initiated, depending upon climatic conditions. Therefore, it may be necessary to combine veterinary medicinal product treatment with environmental treatments aimed at breaking the flea life cycle in the surroundings. This can result in a more rapid reduction in the household flea population. The veterinary medicinal product should be administered at monthly intervals when used as part of a treatment strategy for flea allergy dermatitis.
Treatment of ear mite infestation (Otodectes cynotis)
A single dose of the veterinary medicinal product should be administered. A further veterinary examination 30 days after treatment is recommended as some animals may require a second treatment. Do not apply directly to the ear canal.
Treatment of notoedric mange (Notoedres cati)
A single dose of the veterinary medicinal product should be administered.
Treatment of the lungworm Eucoleus aerophilus (syn. Capillaria aerophila) (adults)
A single dose of the veterinary medicinal product should be administered.
Prevention of Aelurostrongylus abstrusus
The veterinary medicinal product should be administered monthly.
Treatment of Aelurostrongylus abstrusus
The veterinary medicinal product should be administered monthly for three consecutive months.
Treatment of Troglostrongylus brevior (adults)
The veterinary medicinal productshould be administered monthly for two consecutive months.
Treatment of the eye worm Thelazia callipaeda (adults)
A single dose of the veterinary medicinal product should be administered.
Heartworm prevention (Dirofilaria immitis)
Cats in areas endemic for heartworm, or those which have travelled to endemic areas, may be infected with adult heartworms. Therefore prior to treatment with the veterinary medicinal product, the advice provided in section 3.5 should be considered.
For prevention of heartworm disease, the veterinary medicinal product must be applied at regular monthly intervals during the time of the year when mosquitoes (the intermediate hosts which carry and transmit heartworm larvae) are present. The veterinary medicinal product may be administered throughout the year. The first dose may be given after first possible exposure to mosquitoes, but not more than one month after this exposure. Treatment should continue at regular monthly intervals until 1 month after the last exposure to mosquitoes. To establish a treatment routine, it is recommended that the same day or date be used each month. When replacing another heartworm preventative product in a heartworm prevention programme, the first treatment with the veterinary medicinal product must be given within 1 month of the last dose of the former veterinary medicinal product.
In non-endemic areas there should be no risk of cats having heartworm. Therefore, they can be treated without special precautions.
Roundworm and hookworm treatment (Toxocara cati and Ancylostoma tubaeforme)
In areas endemic for heartworm, monthly treatment may significantly reduce the risk of re-infection caused by the respective roundworms and hookworms. In areas non-endemic for heartworm, the veterinary medicinal product can be used as part of a seasonal prevention programme against fleas and gastrointestinal nematodes.
Dosage schedule for ferrets:
One pipette of the veterinary medicinal product (0.4 ml) should be administered per animal. Do not exceed the recommended dose.
For treatment or prevention of infestations with the parasites indicated for use of this veterinary medicinal product, the need for and frequency of re-treatment(s) should be based on professional advice and should take into account the local epidemiological situation and the animal’s lifestyle.
Flea treatment and prevention (Ctenocephalides felis)
One treatment prevents future flea infestation for 3 weeks. Under heavy flea pressure it may be necessary to repeat administration after 2 weeks.
Heartworm prevention (Dirofilaria immitis)
Ferrets in areas endemic for heartworm, or those which have travelled to endemic areas, may be infected with adult heartworms. Therefore prior to treatment with the veterinary medicinal product, the advice provided in section 3.5 should be considered.
For prevention of heartworm disease, the veterinary medicinal product must be applied at regular monthly intervals during the time of the year when mosquitoes (the intermediate hosts which carry and transmit heartworm larvae) are present. The veterinary medicinal product may be administered throughout the year. The first dose may be given after first possible exposure to mosquitoes, but not more than one month after this exposure. Treatment should continue at regular monthly intervals until 1 month after the last exposure to mosquitoes.
In non-endemic areas there should be no risk of ferrets having heartworm. Therefore, they can be treated without special precautions.
Method of administration
External use.
Remove one pipette from the package. Then hold the pipette in an upright position, and twist and pull off the cap. Reverse the cap and use it to twist and remove the seal from the pipette, as shown.
Part the fur on the animal's neck at the base of the skull until the skin is visible. Place the tip of the pipette on the skin and squeeze the pipette firmly several times to empty its contents directly onto the skin. Application at the base of the skull will minimise the opportunity for the animal to lick the veterinary medicinal product. Apply only to undamaged skin.
Adverse reactions
Cats and ferrets:
Rare (1 to 10 animals / 10,000 animals treated): |
Application site greasy fur1 Vomiting1 Hypersensitivity reaction (local) Erythema1 |
Very rare (< 1 animal / 10,000 animals treated, including isolated reports): |
Behavioural disorder (e.g. agitation)2 Hypersalivation3,4 Neurological signs3 Pruritus5 Inappetence2, Lethargy2 |
1 These signs disappear without further treatment.
2 Transiently noted and related to sensation at application site.
3 If the animal licks the application site, in most cases transient.
4 This is not a sign of intoxication and disappears within minutes without treatment. Correct application will minimise licking of the application site.
5 In cats, transient.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Dispensing
POM-V - Prescription Only Medicine – Veterinarian
PRICE | Only for registered vets. Create a free profile to access all features.. Login |
---|---|
Art. Nr. | 04895/5001 |
EAN | 4007221044352 |